The Impact of Oral Health in HIV Patients on Antiretroviral Therapy
Completed
Conditions studied: HIV, Periodontal Diseases, Caries, Non-communicable Disease, Xerostomia
In brief
This is a prospective cohort study designed to investigate the range of metabolic abnormalities observed in patients living with HIV on antiretroviral therapy. This study will also explore the concurrent role of poor oral health in supporting and driving chronic immune activation and inflammation in HIV infection.
Key facts
- Study ID
- NCT04645693
- Run by
- University of Pennsylvania
- People needed
- 227
- Starts
- 2021-02-24
- Expected to finish
- 2026-02-28
- Last updated by the study team
- 2026-05-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥18 years
- Has been diagnosed with HIV (as documented by a prior laboratory report of positive HIV-1/2 antibody and/or detectable HIV RNA, available for review by the study team)
- Has received antiretroviral therapy for at least 12 months
- Able and willing to provide informed consent prior to initiation of study procedures
- Willing and able to comply with all study procedures, and likely to be available for the duration of the study
You may not qualify if…
- Has been diagnosed with the following xerostomia-related autoimmune conditions: Sjorgen's and sarcoidosis
- Has never received radiation therapy to the head or neck (including radioactive iodine therapy)
- Was taking anti-osteoporotic agents (biphosphonates, denosumab) prior to HIV diagnosis.
- Women who are pregnant at the time of enrollment.
Where it is running
- University of Pennsylvania School of Dental Medicine — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.